Am I reading this right?
It looks to me as if pan-European licensing has progressed further than I realised.
Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh)
Companies that have a medicine authorised in one EU Member State can apply for this authorisation to be recognised in other EU countries.
More information is available on:
Coordination Group for Mutual Recognition and Decentralised Procedures – Human
No thyroid mdicines seem to have gone through the processes yet. Nor am I clear exactly what happens when a product has been approved. Can the compnay immediately sell it everywhere? Will Patient Information Leaflets be posted on EMC?
Have we got anyone familiar with the interpretation of EU documents? They are daunting.